Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-124510

Chief Executive Officer acquired 196,316 shares (conversion)

  • Chief Executive Officer returned 196,316 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Santos da Silva Jorge · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-19 Conversion : show line 1 in the form +196,316 3,074,893 D
2025-12-19 Returned to the company : show line 2 in the form −196,316 0 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-19 Conversion : show line 3 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG −5,836 0 D
Loading xslF345X05/ownership.xml…